Follow the Morepen Laboratories Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Morepen Laboratories Limited has recorded 11 reports. Market capitalisation: €31.3bn. The latest transaction was disclosed on 22 September 2022 (Purchase). Among the most active insiders: Mid-Med Financial Services and Investments Private Limited. The full history is openly available.
11
Insider Decl.
n/a
Thresholds
€12m
11 ops.
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
Buys €12mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,952 of 29,113 companies
44.8
score / 100
Value
34
Quality
56
FCF yld-4.1%
Earn yld3.0%
EV/EBITDA19.3x
ROE7.9%
Gross mgn38%
Net mgn5.3%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:6c10a2f9821cf0964d6a51841755e038d17d6b46
11 of 11 declarations
About Morepen Laboratories Limited
Morepen Laboratories Limited is an Indian company engaged in the manufacturing of pharmaceutical products and medical devices. It is listed on the Bombay Stock Exchange and focuses on innovation in the healthcare sector.